Lipodystrophy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lipodystrophy stocks.

Lipodystrophy Stocks Recent News

Date Stock Title
May 6 BMY FDA accepts Bristol Myers application for injected Opdivo
May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
May 6 BMY U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 6 BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 3 BMY Bristol-Myers Squibb: A Lost Decade?
May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
May 1 IONS 4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Apr 30 IONS Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Apr 30 BMY J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
Apr 30 BMY Bristol Myers Squibb: Tough Times Continue
Lipodystrophy

Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".) A more specific term, lipoatrophy, is used when describing the loss of fat from one area (usually the face). This condition is also characterized by a lack of circulating leptin which may lead to osteosclerosis. The absence of fat tissue is associated with insulin resistance, hypertriglyceridemia, non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.

Browse All Tags